請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41658完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 黃青真(Ching-jang, Huang) | |
| dc.contributor.author | "Szu-tzu, Ho" | en |
| dc.contributor.author | 何偲慈 | zh_TW |
| dc.date.accessioned | 2021-06-15T00:26:25Z | - |
| dc.date.available | 2009-02-03 | |
| dc.date.copyright | 2009-02-03 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-01-22 | |
| dc.identifier.citation | 王嘉敏 (1991). '維生素E與氧化性細胞傷害機制之探討.' 台大農化所碩士論文.
李宜靜 (2004). '尿中α-CEHC對於飲食維生素E攝取量之反映評估.' 台大微生物與生化學研究所碩士論文. 劉珍芳 (1993). '炸油飲食對老鼠體內維生素E代謝之影響.' 台大農化所博士論文. 蔡文齡 (1988). '膳食蛋白質、維生素E與包種茶對攝食劣化炸油的老鼠體脂過氧化之影響研究.' 台大農化所碩士論文. 鄭啟承 (2002). '飲食維生素E及clofibric acid對大鼠尿中維生素E代謝物α-CEHC 排出之影響初探.' 台大農化所碩士論文. 羅聲晴 (2006). '以維生素E代謝物α-CEHC於血漿中含量為評估維生素E營養狀 況之可行性探討.' 台大微生物與生化學研究所碩士論文 Bauernfeind, J. C., S. H. Rubin, et al. (1970). 'Carotenoids and fat-soluble vitamins: contribution to food, feed and pharmaceuticals.' Int Z Vitaminforsch 40(3): 391-416. Brigelius-Flohe, R., F. J. Kelly, et al. (2002). 'The European perspective on vitamin E: current knowledge and future research.' Am J Clin Nutr 76(4): 703-16. Brigelius-Flohe, R. and M. G. Traber (1999). 'Vitamin E: function and metabolism.' Faseb J 13(10): 1145-55. Catignani, G. L. (1975). 'An alpha-tocopherol binding protein in rat liver cytoplasm.' Biochem Biophys Res Commun 67(1): 66-72. Cavalier, L., K. Ouahchi, et al. (1998). 'Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families.' Am J Hum Genet 62(2): 301-10. Chiku, S., K. Hamamura, et al. (1984). 'Novel urinary metabolite of d-delta-tocopherol in rats.' J Lipid Res 25(1): 40-8. Desrumaux, C., V. Deckert, et al. (1999). 'Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering alpha-tocopherol to endothelial cells.' Faseb J 13(8): 883-92. Dimitrov, N. V., C. Meyer, et al. (1991). 'Plasma tocopherol concentrations in response to supplemental vitamin E.' Am J Clin Nutr 53(3): 723-9. Eisengart, A., A. T. Milhorat, et al. (1956). 'The metabolism of vitamin E. II. Purification and characterization of urinary metabolites of alpha-tocopherol.' J Biol Chem 221(2): 807-17. Gross, C. S., A. T. Milhorat, et al. (1956). 'The metabolism of vitamin E. I. The absorption and excretion of d-alpha-tocopheryl-5-methyl-C14-succinate.' J Biol Chem 221(2): 797-805. Hayashi, T., A. Kanetoshi, et al. (1992). 'Reduction of alpha-tocopherolquinone to alpha-tocopherolhydroquinone in rat hepatocytes.' Biochem Pharmacol 44(3): 489-93. Hosomi, A., M. Arita, et al. (1997). 'Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs.' FEBS Lett 409(1): 105-8. Ikeda, S., T. Tohyama, et al. (2002). 'Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl- 2(2'-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-tocopherol.' J Nutr 132(5): 961-6. Ingold, K. U., G. W. Burton, et al. (1987). 'Biokinetics of and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat.' Lipids 22(3): 163-72. Kayden, H. J. and L. Bjornson (1972). 'The dynamics of vitamin E transport in the human erythrocyte.' Ann N Y Acad Sci 203: 127-40. Kiyose, C., R. Muramatsu, et al. (1995). 'Biodiscrimination of alpha-tocopherol stereoisomers during intestinal absorption.' Lipids 30(11): 1015-8. Kiyose, C., R. Muramatsu, et al. (1997). 'Biodiscrimination of alpha-tocopherol stereoisomers in humans after oral administration.' Am J Clin Nutr 65(3): 785-9. Kuhlenkamp, J., M. Ronk, et al. (1993). 'Identification and purification of a human liver cytosolic tocopherol binding protein.' Protein Expr Purif 4(5): 382-9. Leichtle, A., D. Teupser, et al. (2006). 'Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects.' J Am Coll Nutr 25(5): 420-8. Leonard, S. W., Y. Terasawa, et al. (2002). 'Incorporation of deuterated RRR- or all-rac-alpha-tocopherol in plasma and tissues of alpha-tocopherol transfer protein--null mice.' Am J Clin Nutr 75(3): 555-60. Li, Y. J., S. C. Luo, et al. (2008). 'Isolation and Identification of alpha-CEHC Sulfate in Rat Urine and an Improved Method for the Determination of Conjugated alpha-CEHC.' J Agric Food Chem. Liebler, D. C., J. A. Burr, et al. (1996). 'Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products.' Anal Biochem 236(1): 27-34. Lodge, J. K., J. Ridlington, et al. (2001). 'Alpha- and gamma-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine.' Lipids 36(1): 43-8. Lodge, J. K., M. G. Traber, et al. (2000). 'A rapid method for the extraction and determination of vitamin E metabolites in human urine.' J Lipid Res 41(1): 148-54. McCay, P. B. (1985). 'Vitamin E: interactions with free radicals and ascorbate.' Annu Rev Nutr 5: 323-40. Morita, T., M. Kitagawa, et al. (1989). 'Tocopherol distribution in serum lipoproteins with respect to red blood cell tocopherol levels in children.' J Nutr Sci Vitaminol (Tokyo) 35(4): 243-51. Parker, R. S., T. J. Sontag, et al. (2000). 'Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin.' Biochem Biophys Res Commun 277(3): 531-4. Schuelke, M., A. Elsner, et al. (2000). 'Urinary alpha-tocopherol metabolites in alpha-tocopherol transfer protein-deficient patients.' J Lipid Res 41(10): 1543-51. Schultz, M., M. Leist, et al. (1995). 'Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?' Am J Clin Nutr 62(6 Suppl): 1527S-1534S. Sies, H. (1993). 'Efficacy of vitamin E in the human.' La Grange,IL:Veris, the Vitamin E Research and Information Servise. Stahl, W., P. Graf, et al. (1999). 'Quantification of the alpha- and gamma-tocopherol metabolites 2,5,7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman and 2,7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman in human serum.' Anal Biochem 275(2): 254-9. Thellman, C. A. and R. B. Shireman (1985). 'In vitro uptake of [3H]alpha-tocopherol from low density lipoprotein by cultured human fibroblasts.' J Nutr 115(12): 1673-9. Traber, M. G., G. W. Burton, et al. (1992). 'Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism.' J Lipid Res 33(8): 1171-82. Traber, M. G., A. Elsner, et al. (1998). 'Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates.' FEBS Lett 437(1-2): 145-8. Traber, M. G. and H. J. Kayden (1984). 'Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein.' Am J Clin Nutr 40(4): 747-51. Traber, M. G. and H. J. Kayden (1989). 'Alpha-tocopherol as compared with gamma-tocopherol is preferentially secreted in human lipoproteins.' Ann N Y Acad Sci 570: 95-108. Traber, M. G., J. C. Lane, et al. (1992). 'Studies on the transfer of tocopherol between lipoproteins.' Lipids 27(9): 657-63. Traber, M. G., T. Olivecrona, et al. (1985). 'Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro.' J Clin Invest 75(5): 1729-34. Traber, M. G., R. Ramakrishnan, et al. (1994). 'Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol.' Proc Natl Acad Sci U S A 91(21): 10005-8. Traber, M. G., L. K. Siddens, et al. (2005). 'Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets.' Free Radic Biol Med 38(6): 773-85. Weimann, B. J. and H. Weiser (1991). 'Functions of vitamin E in reproduction and in prostacyclin and immunoglobulin synthesis in rats.' Am J Clin Nutr 53(4 Suppl): 1056S-1060S. Weiser, H. and M. Vecchi (1981). 'Stereoisomers of alpha-tocopheryl acetate--characterization of the samples by physico-chemical methods and determination of biological activities in the rat resorption-gestation test.' Int J Vitam Nutr Res 51(2): 100-13. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41658 | - |
| dc.description.abstract | 中文摘要
近年的研究報告指出維生素E之尿中代謝產物乃其支鏈僅剩三個碳之carboxyethyl hydroxychroman(CEHC),血漿生育醇濃度超過某一閾值,人體尿中才會有顯著之人體尿中α-CEHC排出,暗示尿中α-CEHC可能與維生素E營養狀況有某種關連。 本論文研究以以大鼠作為動物模式,探討維生素 E 營養狀況與α-CEHC生成量之相關性。先餵食 48隻雄性離乳 Wistar 大鼠缺維生素E飼料一週後,隨機分成8組,其中7組分別餵食不同0,5,10,15,25,35,75 mg/kg diet RRR-α-tocopheryl acetate(E0、E5、E10、E15、E25、E35及E75組飼料)之實驗飼料,另一組則餵食102 mg/kg diet all-rac-α-tocopheryl acetate之實驗飼料(EA組飼料)8、10週及13.5週,於第 0、50∼56、64∼70天及第90∼94天起將各組大鼠鼠移至代謝籠,收集每天之 24 小時尿液,記錄各鼠每日攝水量與排尿量。最後,經禁食隔夜後於第94天犧牲。 結果顯示,8組鼠中,只有E0組之血漿Pyruvarte kinase活性顯著較其他各組較高(p<0.05),紅血球體外溶血率亦只有E0組顯著較高(p<0.05),於8週、10週及13.5週分別達91%、87%及95%。血漿α-tocopherol 濃度方面,E0、E5、E10 、E25、E35、E75為E15組之0.09、0.3、0.63、1.01、1.38、1.61及1.74倍。肝臟α-tocopherol含量方面,E0、E5、E10 、E25、E35、E75分別為E15組之0.09、0.34、0.68、1.21、1.78及3.31倍。副睪脂α-tocopherol 含量方面,E0、E5、E10、 E25、E35、E75分別為E15組之1.4、0.72、1.3、2.83(p<0.05)、1.46及2.43倍。而EA組與E75皆無顯著差異(p>0.05)。以上各指標除脂肪組織的α-tocophero外,在飲食維生素E含量0∼75mg/kg diet之範圍內反應皆靈敏,皆和飲食維生素E攝取量呈現高度正相關。尤以肝臟α-tocopherol之相關性最佳。 8組尿液α-CEHC排出量於0週並無顯著差異(p>0.05),皆很低。餵食實驗飼料8週後除E0組外均有上升,且隨飲食維生素 E 攝取量增加而顯著提升。於餵食13.5週後,Free α-CEHC方面,E0、E5、E10 、E25、E35、E75分別為E15組之1.14、0.88、 1.03、1.2、1.32及2.66倍(p<0.05)。Conjugated α-CEHC方面,E0、E5、E10 、E25、E35、E75分別為E15組之0.17、0.42、0.67、1.78、3.78及9.95倍(p<0.05)。Total α-CEHC方面, E0、E5、E10 E25、E35、E75為E15組之0.14、0.43、0.68、1.77、3.73及8.91倍。而EA組與E75組於13.5週後無顯著差異。血漿中α-CEHC 濃度亦隨飲食維生素 E 攝取量增加而顯著提升。Free α-CEHC方面,E0、E5、E10 、E25、E35、E75分別為E15組之0.17、0.27、0.82、0.86、1.26及1.53倍。Conjugated α-CEHC方面,E0、E5、E10 、E25、E35、E75分別為E15組之0.44、0.79、0.98、2.61、3.24及4.6倍。Total α-CEHC方面, E0、E5、E10 E25、E35、E75為E15組之0.35、0.61、0.93、2.01、2.57及3.55倍。而EA組與E75亦無顯著差異。 將α-CEHC、血漿及組織α-tocopherol含量與飲食維生素E攝入量進行相關性分析,以肝臟α-tocopherol含量與飲食維生素E攝入量相關係數最高(r =0.96, p<0.0001),其次是血漿conjugated α-CEHC(r = 0.9, p<0.0001)及total α-CEHC(r = 0.88, p<0.0001),高於血漿α-tocopherol(r = 0.79, p<0.0001)。尿中conjugated α-CEHC排出量與飲食維生素E攝取量之相關性(r = 0.78, p<0.0001)與血漿α-tocopherol和飲食維生素攝取量之相關性接近。 總結,於飼料維生素E含量0∼15 mg/kg diet範圍中,血漿和肝臟α-tocopherol與飲食維生素E攝取量反應靈敏。尿液和血漿α-CEHC則於25∼75及0∼25 mg/kg diet之範圍中反應較佳。此外,在0∼75 mg/kg diet之範圍中,尿液α-CEHC與飲食維生素E攝取量之相關性,與血漿α-tocopherol相近,而血漿α-CEHC及肝臟α-tocopherol含量則與飲食維生素E攝取量相關性更高。血漿α-CEHC供為維生素E營養狀況之生化指標的潛力,值得進一步深究。 | zh_TW |
| dc.description.abstract | Abstract
2, 5, 7,8-tetramethyl-2-(2’-carboxyethyl)-6-hydroxychroman (α-CEHC) has been demonstrated to be the urinary metabolite of α-tocopherol. It has been reported that α-CEHC could be detected in the human urine while the plasma α-tocopherol concentration of the subject was higher than a threshold value (Shultz et al., 1995),implying that the urinary α-CEHC excretion might be related to the nutritional status of vitamin E. To characterizing the quantitative relationship between α-CEHC level and dietary α-tocopherol intake, rats were fed diets of which the vitamin E level ranged from 0 to 75 mg/kg diet. The response of α-CEHC in urine and plasma to increasing intake of vitamin E were compared to other biomarkers of vitamin E status. Forty-eight weanling Wistar rats were fed vitamin E-deficient diet for 1 week. They were then randomly assigned to eight groups and respectively fed diets containing 0 (E0), 5 (E5), 10 (E10), 15 (E15), 25 (E25), 35 (E35) or 75 (E75) mg/kg diet of RRR-α-tocopheryl acetate or 102mg/kg diet of all-rac-α-tocopheryl acetate(EA) for 13.5 weeks. Twenty-four hour urine was collected and daily water intake recorded on week 8, 10 and 13.5. After an overnight fasting, rats were sacrificed on day 94. Among the 8 groups, only E0 showed significantly higher plasma pyruvate kinase activity as well as the in vitro RBC hemolysis.(p < 0.05) The plasma α-tocopherol concentration of the E0,E5,E10, E25,E35 and E75 group were respectively 0.09, 0.3, 0.63,1.01, 1.38, 1.61and 1.74 fold that of the E15 group. The liver α-tocopherol content of the E0, E5, E10, E25, E35 and E75 group were 0.09, 0.34, 0.68, 1.21, 1.78 and 3.31 fold that of the E15 group. The EWAT α-tocopherol content of the E0,E5,E10, E25,E35 and E75 group were 1.14, 0.72, 1.3, 2.83, 1.46 and 2.43 fold that of the E15 group. The linear relationship between plasma α-tocopherol and dietary vitamin E level was sharper in the range of 0-15 mg/kg diet than in the range of 25-75 mg/kg diet. The correlation coefficient between α-tocopherol level and vitamin E intake in the range of 0 to 75 mg/kg diet was highest with the liver. The urinary α-CEHC excretion of the 8 groups were not significant different in week 0. After 8 weeks , the urinary α-CEHC excretion markedly increased with the increase of the dietary vitamin E level. The excretion (μg/day) of free α-CEHC of E0,E5,E10, E25,E35 and E75 group were 1.14, 0.88, 1.03, 1.2, 1.32 and 2.66 (p<0.05)fold that of the E15 group, respectively. The excretion of conjugated α-CEHC of E0,E5,E10, E25,E35 and E75 group were 0.17, 0.42, 0.67,1.78, 3.78 and 9.95 fold that of E15 group, respectively. The excretion of total α-CEHC of E0,E5,E10, E25,E35 and E75 group were0.14, 0.43, 0.68, 1.77, 3.73 and 8.91 fold that of the E15 group, respectively. EA showed significant difference with E75 after 13.5 weeks. The plasma α-CEHC concentration also increased markedly with the increase of dietary vitamin E level. The plasma concentration (μM) of free α-CEHC of E0,E5,E10, E25,E35 and E75 group were 0.17, 0.27, 0.82, 0.86, 1.26 and 1.53 fold that of the E15 group, respectively. The concentration(μM) of conjugated α-CEHC of E0,E5,E10, E25,E35 and E75 group were 0.44, 0.79, 0.98, 2.61, 3.24 and 4.6 fold that of the E15 group, respectively. The concentration (μM) of total α-CEHC of E0,E5,E10, E25,E35 and E75 group were0.35, 0.61, 0.93, 2.01, 2.57 and 3.55 fold that of the E15 group, respectively. EA also showed no significant difference with E75. The correlation of various responder to dietary vitamin intake were found to be highest with the liver α-tocopherol content (r = 0.96, p<0.000), and the plasma conjugated α-CEHC(r = 0.9, p<0.000) and total α-CEHC(r = 0.88, p<0.000) were next to it. In conclusion, the plasma and liverα--tocopherol responded more sharply to dietary vitamin E level in the range between 0-15 mg/kg diet of RRR-α-tocopheryl acetate while plasma and urinary α-CEHC responded more sharply to dietary vitamin E intake in the range between 0-25 and 25-75 mg/kg diet. The results implied the potential of using the plasma α-CEHC as an indicator of dietary vitamin E intake beyond the adequate level. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T00:26:25Z (GMT). No. of bitstreams: 1 ntu-98-R95b47305-1.pdf: 1425591 bytes, checksum: 938db8313a02a3880d22f7b533a34514 (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 總目錄
論文口試委員會審定書................................................................................................... I 中文摘要.........................................................................................................................Ⅲ 英文摘要.........................................................................................................................Ⅴ 縮寫對照表.................................................................................................................... IX 第一章 緒言....................................................................................................................1 第一節 研究動機與目的.................................................................................................1 第二節 文獻回顧.............................................................................................................3 一、維生素E 之簡介與功能...........................................................................................3 (一) 維生素E 之結構特性...............................................................................................3 (二) 維生素E 之來源.......................................................................................................3 (三) 維生素E 之功能.......................................................................................................4 (四) 維生素E 之吸收、運轉與儲存..............................................................................4 (五) 維生素E 之生物活性及生物利用率......................................................................8 (六) α-tocopherol transfer protein(α-TTP) .......................................................................9 二、維生素E 的代謝途徑..............................................................................................9 (一) 維生素E 抗氧化代謝途徑與肝中代謝物..............................................................9 (二) 維生素E 抗氧化代謝與尿中代謝物:Simon’s metabolites................................11 (三) 維生素E 非抗氧化之代謝產物:α-CEHC 之發現...............................................13 (四) α-TTP 與α-CEHC 生成之關係...............................................................................15 (五)目前推測α-tocopherol 代謝為α-CEHC 的代謝途徑.............................................17 三、Biotransformation 之簡介.......................................................................................18 (一)PhaseІ 及PhaseП 反應............................................................................................ 18 (二) PhaseІ 反應及Cytochrome P450 ...........................................................................18 (三)維生素E 與CytochromeP450 之關係.....................................................................20 (四) PhaseП 反應.............................................................................................................20 (五)α-CEHC conjugates..................................................................................................21 四、目前關於α-CEHC 之相關研究..............................................................................22 第三節 實驗設計與目的...............................................................................................22 第二章 大鼠維生素攝取量由不足至充足對其尿液及血漿中α-CEHC 含量之影25 第一節 前言...................................................................................................................25 第二節 材料與方法.......................................................................................................27 一、實驗設計..................................................................................................................27 二、劑量設計概念...........................................................................................................28 三、實驗飼料配製...........................................................................................................28 四、動物飼養...................................................................................................................31 五、動物犧牲、樣品收集與前處理...............................................................................31 六、紅血球體外溶血試驗..............................................................................................32 七、Pyruvate kinase 活性測定.........................................................................................32 八、油脂中維生素E 之定量..........................................................................................33 九、血漿α-tocopherol 含量分析....................................................................................35 十、組織α-tocopherol 含量分析....................................................................................37 十一、尿液Creatinine 含量分析....................................................................................39 十二、尿液α-CEHC 含量分析......................................................................................39 十三、血漿α-CEHC 含量分析......................................................................................41 十四、統計分析..............................................................................................................42 第三節 結果...................................................................................................................43 一、經活性碳處理後新鮮大豆油維生素E 含量............................................................43 二、生長狀況..................................................................................................................43 (一) 體重變化與飼料利用情形.....................................................................................43 (二) 組織重量.................................................................................................................43 三、維生素E 營養狀況不良指標.................................................................................44 (一) 血漿丙酮酸激酶(PK)活性.....................................................................................44 (二) 紅血球體外溶血率變化.........................................................................................44 四、水分攝取量與尿液排出量......................................................................................44 五、尿液Creatinine 含量...............................................................................................45 六、血漿α-tocopherol 濃度...........................................................................................45 七、組織α-tocopherol 含量變化......................................................................................46 (一) 肝臟α-tocopherol 含量變化...................................................................................46 (二) 副睪脂α-tocopherol 含量變化..............................................................................47 八、尿液α-CEHC 排出量變化.......................................................................................47 Baseline 尿液α-CEHC 排出量................................................................................48 第8、10 和13.5 週尿液α-CEHC排出量.................................................................48 (一) 尿液Free α-CEHC 排出量.....................................................................................49 (二) 尿液Conjugated α-CEHC 排出量..........................................................................50 (三)尿液Total α-CEHC 排出量...................................................................................51 (四) Free 及Conjugated α-CEHC 佔Total α-CEHC 之比例...........................................52 九、血漿α-CEHC 濃度..................................................................................................52 (一) 血漿Free α-CEHC 濃度變化..................................................................................52 (二) 血漿Conjugated α-CEHC 濃度變化......................................................................53 (三) 血漿Total α-CEHC 濃度變化.................................................................................53 十、相關性分析...............................................................................................................54 (一) 飲食維生素E 攝取量與各因子之相關性分析......................................................54 (二) 尿液、血漿中α-CEHC 及其排出比例與各因子之相關性分析..........................55 第四節 討論..................... ................................................................ ............................97 一、血漿Pyruvate kinase 活性和紅血球體外溶血率只能偵測嚴重維生素E 缺乏97 二、比較肝臟、副睪脂與血漿中α-tocopherol 之變化...................................................97 三、血漿α-tocopherol 濃度、肝臟α-tocopherol 和副睪脂α-tocopherol 含量對於維 素E 營養狀況之反應性..........................................................................................97 四、尿液和血漿中各型式α-CEHC 含量對於維生素E 營養狀況之反應性..............98 五、比較尿液和血漿中Conjugated α-CEHC 佔Total α-CEHC 的比例不同.............99 六、尿液及血漿中各型式α-CEHC 含量與血漿α-tocopherol 濃度、肝臟α-tocopherol 含量兩項生化指標顯著相關...................................................................................99 七、RRR -α-tocopheryl acetate 及all-rac-α-tocopheryl acetate 之比較.........................99 八、α-CEHC 之代謝之重要意義...................................................................................100 第三章 總結.................................................................................................................101 第四章 參考文獻.........................................................................................................103 圖目錄 圖1-1 α-tocopherol 和α-CEHC 之結構............................................................................2 圖1-2 α-tocopherol 與自由基反應之代謝途徑及其產物結構... ...............................11 圖1-3 Simon’s metabolites...........................................................................................12 圖1-4 α-tocopherol 可能的代謝途徑..........................................................................15 圖2-1 餵食實驗飼料13.5週大鼠之生長曲線...............................................................82 圖2-2 餵食實驗飼料8、10、13.5週大鼠之丙酮酸激酶活性.........................................83 圖2-3 餵食實驗飼料8、10、13.5週大鼠之體外紅血球溶血率....................................84 圖2-4 餵食大鼠實驗飼料13.5週之血漿α-tocopherol 濃度......................................85 圖2-5 餵食實驗飼料13.5週大鼠之肝臟α-tocopherol 含量............. ........................86 圖2-6 餵食實驗飼料13.5週大鼠之副睪脂α-tocopherol 含量........ .........................87 圖2-7 餵食實驗飼料13.5週後大鼠之尿液α-CEHC排出量.... ..................................88 圖2-8 餵食實驗飼料13.5週大鼠之血漿α-CEHC濃度之影響. .................................89 圖2-9 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與血漿α-tocopherol濃度 之相關性分析.....................................................................................................90 圖2-10 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與肝臟α-tocopherol 含量之相關性分析. .........................................................................................90 圖2-11 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與副睪脂α-tocopherol含 量之相關性分析...............................................................................................91 圖2-12 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與尿液Freeα-CEHC排 出量之相關性分析...........................................................................................92 圖2-13 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與尿液Conjugatedα -CEHC排出量之相關性分析...........................................................................93 圖2-14 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與尿液Total α-CEHC排出量之相關性分析...........................................................................................93 圖2-15 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與血漿α-CEHC濃度之 相關性分析.......................................................................................................94 圖2-16 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與血漿Conjugated α-CEHC濃度之相關性分析.............................................................................94 圖2-17 餵食實驗飼料13.5週大鼠平均每日維生素E攝取量與血漿Total α-CEHC濃 度之相關性分析...............................................................................................95 表目錄 表2-1 實驗飼料組成.....................................................................................................30 表2-2 經活性碳處理後新鮮大豆油中維生素E 含量..................................................43 表2-3 餵食實驗飼料大鼠13.5 週之初體重、終體重、體重增加量、總攝食量、飼 料利用效率及維生素E 攝取量.........................................................................57 表 2-4 餵食實驗飼料13.5 週大鼠之脂肪組織絕對重量............................................58 表2-5 餵食實驗飼料8、10、13.5 週大鼠之紅血球體外溶血率及血漿丙酮酸激酶活 性.........................................................................................................................59 表2-6 餵食實驗飼料8、10、13.5 週大鼠之攝水量、排尿量.........................................60 表2-7 餵食實驗飼料8、10、13.5 週大鼠之尿液creatinine 含量..............................61 表2-8 餵食實驗飼料13.5 週大鼠之血漿α-tocopherol 濃度之影響...........................62 表2-9 餵食實驗飼料13.5 週大鼠之肝臟α-tocopherol 含量........................................63 表2-10 餵食實驗飼料13.5 週大鼠之副睪脂α-tocopherol 含量之影響.....................64 表2-11 餵食實驗飼料前大鼠之尿液Free 與α-CEHC 排出量(baseline 數值) ........65 表2-12 餵食實驗飼料前大鼠之尿液Total α-CEHC排出量(baseline 數值) ..............66 表2-13 餵食實驗飼料8 週大鼠之尿液Free 與Conjugated α-CEHC 排出量...........67 表2-14 餵食實驗飼料8 週大鼠之尿液Total α-CEHC排出量....................................68 表2-15 餵食大鼠實驗飼料10 週之尿液Free 與Conjugated α-CEHC 排出量..........69 表2-16 餵食實驗飼料10 週大鼠之尿液Total α-CEHC排出量..................................70 表2-17 餵食大鼠實驗飼料13.5 週之尿液Free 與Conjugated α-CEHC.....................71 表2-18 餵食實驗飼料13.5 週大鼠之尿液Total α-CEHC 排出量...............................72 表2-19 以餵食實驗飼料之週數與實驗飼料維生素E 含量對尿液Free、Conjugated、 Total α-CEHC 及排出比例之影響...................................................................73 表2-20 餵食實驗飼料8、10 及13.5 週各組大鼠飲食中之維生素E 含量和其尿液各型式α-CEHC 排出量之比例關係..................74 表2-21 餵食實驗飼料13.5 週大鼠之血漿α-CEHC 濃度............................................75 表2-22 血漿α-tocopherol 濃度、肝臟α-tocopherol 含量、副睪脂α-tocopherol 含 量、攝水量及排尿量與飲食維生素E 攝取量之相關性分析..........................76 表2-23 尿液中各型式α-CEHC 排出量、Free α-CEHC 及Conjugated α-CEHC 佔Total α-CEHC 排出量之比例與飲食維生素E 攝取量之相關性分析...77 表2-24 血漿中各型式α-CEHC 排出量、Free α-CEHC 及Conjugated α-CEHC 佔Total α-CEHC排出量之比例與飲食維生素E攝取量之相關性分析.....78 表2-25 尿液中各型式α-CEHC 排出量、Free α-CEHC 及Conjugated α-CEHC 佔Total α-CEHC 排出量之比例與血漿α-tocopherol 濃度、肝臟α -tocopherol 含量、副睪脂α-tocopherol 含量之相關性分析..........................79 表2-26 血漿中各型式α-CEHC 濃度、Free α-CEHC 及Conjugated α-CEHC 佔 Total α-CEHC 排出量之比例與血漿α-tocopherol 濃度、肝臟α -tocopherol 含量、副睪脂α-tocopherol 含量之相關性分析...........................80 | |
| dc.language.iso | zh-TW | |
| dc.subject | 血漿α-CEHC | zh_TW |
| dc.subject | Wistar大鼠 | zh_TW |
| dc.subject | 維生素E攝取量 | zh_TW |
| dc.subject | 尿液α-CEHC | zh_TW |
| dc.subject | Plasma α-CEHC | en |
| dc.subject | Urinary α-CEHC | en |
| dc.subject | Vitamin E intake | en |
| dc.subject | Wistar rat | en |
| dc.title | 大鼠尿液及血漿中維生素E代謝物α-CEHC
對維生素E營養狀況之反應性 | zh_TW |
| dc.title | Response of Urinary and Plasma α-CEHC
to Vitamin E Status in Rats | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 胡淼琳(Miao-lin, Hu),林璧鳳(Bi-fong, Lin),劉珍芳(Jen-fang, Liu),蕭慧美(Huey-mei, Shaw) | |
| dc.subject.keyword | Wistar大鼠,維生素E攝取量,尿液α-CEHC,血漿α-CEHC, | zh_TW |
| dc.subject.keyword | Wistar rat,Vitamin E intake,Urinary α-CEHC,Plasma α-CEHC, | en |
| dc.relation.page | 107 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-01-22 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 微生物與生化學研究所 | zh_TW |
| 顯示於系所單位: | 微生物學科所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 1.39 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
